Christopher C. Lai

796 total citations
24 papers, 432 citations indexed

About

Christopher C. Lai is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, Christopher C. Lai has authored 24 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Organic Chemistry and 6 papers in Infectious Diseases. Recurrent topics in Christopher C. Lai's work include HIV/AIDS drug development and treatment (6 papers), Chemical Synthesis and Analysis (5 papers) and Peptidase Inhibition and Analysis (4 papers). Christopher C. Lai is often cited by papers focused on HIV/AIDS drug development and treatment (6 papers), Chemical Synthesis and Analysis (5 papers) and Peptidase Inhibition and Analysis (4 papers). Christopher C. Lai collaborates with scholars based in United States, China and Canada. Christopher C. Lai's co-authors include James A. Kelley, Yan‐Ping He, Belinda Wilson, Jau‐Shyong Hong, Ling‐Yuan Kong, Martin W. Brechbiel, Diane E. Milenic, Celeste A.S. Regino, Kwamena E. Baidoo and C. Andrew Boswell and has published in prestigious journals such as Nature Communications, PLoS ONE and Small.

In The Last Decade

Christopher C. Lai

24 papers receiving 422 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher C. Lai United States 13 165 105 88 84 68 24 432
Yoshiyuki Taoda Japan 12 257 1.6× 129 1.2× 153 1.7× 104 1.2× 28 0.4× 23 588
Lynne Rainen United States 11 350 2.1× 94 0.9× 37 0.4× 57 0.7× 168 2.5× 14 659
Davide Carta Italy 14 200 1.2× 195 1.9× 138 1.6× 55 0.7× 93 1.4× 35 535
K.A. Walter United States 6 338 2.0× 64 0.6× 36 0.4× 71 0.8× 63 0.9× 9 513
Angela L. Perkins United States 10 200 1.2× 87 0.8× 9 0.1× 56 0.7× 68 1.0× 17 429
Renata Kaczmarek Poland 12 268 1.6× 86 0.8× 20 0.2× 101 1.2× 51 0.8× 37 417
Yucheng Wang China 13 106 0.6× 66 0.6× 24 0.3× 78 0.9× 21 0.3× 29 353
Erik Prell Germany 13 213 1.3× 78 0.7× 16 0.2× 96 1.1× 46 0.7× 25 419
Paul Aiyetan United States 10 403 2.4× 79 0.8× 59 0.7× 14 0.2× 62 0.9× 17 520
Francis J. Woerner United States 11 157 1.0× 187 1.8× 15 0.2× 119 1.4× 14 0.2× 15 422

Countries citing papers authored by Christopher C. Lai

Since Specialization
Citations

This map shows the geographic impact of Christopher C. Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher C. Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher C. Lai more than expected).

Fields of papers citing papers by Christopher C. Lai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher C. Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher C. Lai. The network helps show where Christopher C. Lai may publish in the future.

Co-authorship network of co-authors of Christopher C. Lai

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher C. Lai. A scholar is included among the top collaborators of Christopher C. Lai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher C. Lai. Christopher C. Lai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rhodes, Curran A., Desta Doro Bume, Colleen M. Connelly, et al.. (2021). A chemical probe based on the PreQ1 metabolite enables transcriptome-wide mapping of binding sites. Nature Communications. 12(1). 5856–5856. 35 indexed citations
2.
Majumder, Poulami, Marcos Iglesias, Lixin Fan, et al.. (2020). Multiphase Assembly of Small Molecule Microcrystalline Peptide Hydrogel Allows Immunomodulatory Combination Therapy for Long‐Term Heart Transplant Survival. Small. 16(38). e2002791–e2002791. 19 indexed citations
3.
Yang, Liu‐Meng, Wei Ding, Jiangyuan Wang, et al.. (2019). Synthesis and biological evaluation of a series of 2-(((5-akly/aryl-1H-pyrazol-3-yl)methyl)thio)-5-alkyl-6-(cyclohexylmethyl)-pyrimidin-4(3H)-ones as potential HIV-1 inhibitors. Acta Pharmaceutica Sinica B. 10(3). 512–528. 33 indexed citations
4.
Chang, Jie, Jiangyuan Wang, Peng Zhong, et al.. (2018). 3D-QSAR Studies of S-DABO Derivatives as Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors. Letters in Drug Design & Discovery. 16(8). 868–881. 2 indexed citations
5.
Elhalem, Eleonora, Xiaoling Zhou, Nancy E. Lewin, et al.. (2017). Exploring the influence of indololactone structure on selectivity for binding to the C1 domains of PKCα, PKCε, and RasGRP. Bioorganic & Medicinal Chemistry. 25(12). 2971–2980. 8 indexed citations
6.
Qian, Wen‐Jian, Jung‐Eun Park, Robert A. Grant, et al.. (2015). Neighbor‐directed histidine N (τ)–alkylation: A route to imidazolium‐containing phosphopeptide macrocycles. Biopolymers. 104(6). 663–673. 12 indexed citations
7.
8.
Qian, Wen‐Jian, Christopher C. Lai, James A. Kelley, & Terrence R. Burke. (2014). Design and Synthesis of Fmoc‐Thr[PO(OH)(OPOM)] for the Preparation of Peptide Prodrugs Containing Phosphothreonine in Fully Protected Form. Chemistry & Biodiversity. 11(5). 784–791. 3 indexed citations
9.
10.
Liu, Xiaofeng, Lihe Lu, Hua Wang, et al.. (2013). Synthesis and Biological Evaluation of Novel Hydroxylphenethyl-S-DACOs as High Active Anti-HIV Agents. Letters in Drug Design & Discovery. 10(3). 271–276. 1 indexed citations
11.
Lee, Dana, Shaun G. Goodman, Keith A.A. Fox, et al.. (2013). Prognostic significance of presenting blood pressure in non–ST-segment elevation acute coronary syndrome in relation to prior history of hypertension. American Heart Journal. 166(4). 716–722. 16 indexed citations
12.
Liu, Xiaofeng, Hua Wang, Cong Li, et al.. (2013). Synthesis and Biological Evaluation of Novel Hydroxylphenethyl-SDACOs as High Active Anti-HIV Agents. Letters in Drug Design & Discovery. 10(3). 271–276. 8 indexed citations
13.
Goodman, Shaun G., Raymond T. Yan, Ron Wald, et al.. (2010). Comparison of Baseline Characteristics, Management and Outcome of Patients With Non–ST-Segment Elevation Acute Coronary Syndrome in Versus Not in Clinical Trials. The American Journal of Cardiology. 106(10). 1389–1396. 31 indexed citations
14.
He, Yan‐Ping, Cong Li, Christopher C. Lai, et al.. (2010). Synthesis and biological evaluation of novel dihydro-aryl/alkylsulfanyl-cyclohexylmethyl-oxopyrimidines (S-DACOs) as high active anti-HIV agents. Bioorganic & Medicinal Chemistry Letters. 21(2). 694–697. 33 indexed citations
15.
Russ, Pamela, María J. González‐Moa, B. Christie Vu, et al.. (2009). North‐ and South‐Bicyclo[3.1.0]Hexene Nucleosides: The Effect of Ring Planarity on Anti‐HIV Activity. ChemMedChem. 4(8). 1354–1363. 4 indexed citations
16.
Boswell, C. Andrew, Celeste A.S. Regino, Kwamena E. Baidoo, et al.. (2008). A novel side-bridged hybrid phosphonate/acetate pendant cyclam: Synthesis, characterization, and 64Cu small animal PET imaging. Bioorganic & Medicinal Chemistry. 17(2). 548–552. 28 indexed citations
17.
18.
Jiang, Sheng, Peng Li, Christopher C. Lai, James A. Kelley, & Peter P. Roller. (2006). Design and Concise Synthesis of Fully Protected Analogues of l-γ-Carboxyglutamic Acid. The Journal of Organic Chemistry. 71(19). 7307–7314. 11 indexed citations
19.
Lai, Christopher C., et al.. (2005). Synthesis and biological study of a flavone acetic acid analogue containing an azido reporting group designed as a multifunctional binding site probe. Bioorganic & Medicinal Chemistry. 13(8). 2717–2722. 11 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoshiyuki Taoda Breakdown of academic impact, for papers by Lynne Rainen Breakdown of academic impact, for papers by Davide Carta Breakdown of academic impact, for papers by K.A. Walter Breakdown of academic impact, for papers by Angela L. Perkins Breakdown of academic impact, for papers by Renata Kaczmarek Breakdown of academic impact, for papers by Yucheng Wang Breakdown of academic impact, for papers by Erik Prell Breakdown of academic impact, for papers by Paul Aiyetan Breakdown of academic impact, for papers by Francis J. Woerner
Rankless by CCL
2026